Skip to main content
. 2023 Mar 20;37(15):3145–3156. doi: 10.1038/s41433-023-02483-2

Table 4.

Results of meta-analysis PD vs. control.

Variables Overall Effect Heterogeneity
Mean Difference (95% CI) P -value I2 Test, % Q Test (P)
Optovue SCP VD
parafoveal -0.71 (-2.81 to 1.37) 0.50 77.56 0.008
Superior -0.78 (-3.77 to 2.20) 0.60 79.170 0.02
Inferior -0.72 (-4.50 to 3.06) 0.70 87.37 0.004
Foveal 0.56 (-1.26 to 2.39) 0.54 0.00 0.73
DCP VD
Parafoveal -0.61 (-1.78 to 0.56) 0.30 0.00 0.75
Superior -0.39 (-1.96 to 1.16) 0.61 0.00 0.64
Inferior -0.24 (-1.75 to 1.26) 0.74 0.00 0.53
Foveal 0.64 (-1.27 to 2.55) 0.51 0.00 0.85
RPC VD 0.61 (-0.04 to 1.27) 0.06 0.00 0.74-
Zeiss SCP VD
Parafoveal -1.14 (-2.58 to 0.29) 0.11 71.25 0.06
Perifoveal -0.29 (-0.59 to 0.01) 0.06 0.00 0.66
Foveal -1.97 (-2.97 to -0.97) 0.0001 0.00 0.46
Whole -1.01 (-2.59 to 0.57) 0.21 78.58 0.03
FAZ area -0.02 (-0.07 to 0.03) 0.49 88.35 0.002

SCP superficial capillary plexus, DCP deep capillary plexus, RPC radial peripapillary capillaries, FAZ foveal avascular zone, VD vessel density, PFD perfusion density, CI confidence interval.

Boldface values indicate the significance of the 95% confidence limit.